Mostrar el registro sencillo del ítem

dc.contributor.authorPorteiro, B.
dc.contributor.authorDíaz-Ruíz, A.
dc.contributor.authorMartínez, G.
dc.contributor.authorSenra, A.
dc.contributor.authorVidal, A.
dc.contributor.authorSerrano, M.
dc.contributor.authorGualillo ., Oreste 
dc.contributor.authorLópez, M.
dc.contributor.authorMalagón, M. M.
dc.contributor.authorDiéguez, C.
dc.contributor.authorNogueiras, R.
dc.date.accessioned2017-06-07T07:11:47Z
dc.date.available2017-06-07T07:11:47Z
dc.date.issued2013
dc.identifier.issn0013-7227
dc.identifier.urihttp://hdl.handle.net/20.500.11940/3698
dc.description.abstractGhrelin, a stomach-derived peptide, stimulates feeding behavior and adiposity. For its orexigenic action, ghrelin triggers a central SIRT1/p53/AMPK pathway. The tumor suppressor p53 also plays an important role in white adipose tissue (WAT), where it is up-regulated in the adipocytes of obese mice. It is not known, however, whether p53 has any role in mediating the peripheral action of ghrelin. In the present study, chronic peripheral ghrelin treatment resulted in increased body weight and fat-mass gain in wild-type mice. Correspondingly, mRNA levels of several adipogenic and fat-storage-promoting enzymes were up-regulated in WAT, whereas hepatic triglyceride content and lipogenic enzymes were also increased in wild-type mice following ghrelin treatment. In contrast, mice lacking p53 failed to respond to ghrelin treatment, with their body weight, fat mass, and adipocyte and hepatic metabolism remaining unchanged. Thus, our results show that p53 is necessary for the actions of ghrelin on WAT and liver, leading to changes in expression levels of lipogenic and adipogenic genes, and modifying body weight.
dc.language.isoeng
dc.subject.meshAdipogenesis
dc.subject.meshAdipose Tissue, White
dc.subject.meshAdiposity
dc.subject.meshAnimals
dc.subject.meshCrosses, Genetic
dc.subject.meshEnzyme Induction
dc.subject.meshFemale
dc.subject.meshGene Expression Profiling
dc.subject.meshGhrelin
dc.subject.meshInjections, Intraperitoneal
dc.subject.meshLipogenesis
dc.subject.meshLiver
dc.subject.meshMale
dc.subject.meshMice
dc.subject.meshMice, 129 Strain
dc.subject.meshMice, Inbred C57BL
dc.subject.meshMice, Knockout
dc.subject.meshObesity
dc.subject.meshTissue Culture Techniques
dc.subject.meshTriglycerides
dc.subject.meshTumor Suppressor Protein p53
dc.subject.meshWeight Gain
dc.titleGhrelin requires p53 to stimulate lipid storage in fat and liver
dc.typeArtigoes
dc.authorsophosPorteiro, B.
dc.authorsophosDíaz-Ruíz, A.
dc.authorsophosMartínez, G.
dc.authorsophosSenra, A.
dc.authorsophosVidal, A.
dc.authorsophosSerrano, M.
dc.authorsophosGualillo, O.
dc.authorsophosLópez, M.
dc.authorsophosMalagón, M. M.
dc.authorsophosDiéguez, C.
dc.authorsophosNogueiras, R.
dc.identifier.doi10.1210/en.2013-1176
dc.identifier.isi324759600020
dc.identifier.pmid23832961
dc.identifier.sophos13503
dc.issue.number10
dc.journal.titleEndocrinology
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago
dc.page.initial3671
dc.page.final3679
dc.relation.publisherversionhttps://academic.oup.com/endo/article-pdf/154/10/3671/13060314/endo3671.pdf
dc.rights.accessRightsopenAccess
dc.typesophosArtículo Original
dc.volume.number154


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem